The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...
A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...
Tempus AI is projected to achieve 30% YoY top line growth in Q4 2024 as presented in its preliminary results. Click here to ...
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...
It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...
She was previously the supplier's head of commercial excellence for Europe, Middle East, Africa & Latin America ...
They call themselves Speed to Market, a group of life sciences and real estate professionals who find, build and sell manufacturing space for biotech employers around Philadelphia. During the COVID ...
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...
Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...
GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I've ...
The aging population and lifestyle-related factors contribute to a surge in pancreatic cancer cases. The aggressive nature of the disease and its high mortality rate demand innovative therapies.